GlassScriptPhysician profile
Michael B Banffy
NPI 1558497982
$577,710.81
in general payments reported to CMS, 2019-2025
17 companies · $151K in 2025
The $151K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $62K · 2021: $119K · 2022: $61K · 2023: $66K · 2024: $69K · 2025: $151K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $172K · Travel and Lodging: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Honoraria: $14K · Royalty Or License: $14K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $171,591.25 |
| Travel and Lodging | $32,630.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,471.64 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,900.00 |
| Honoraria | $13,750.00 |
| Royalty Or License | $13,686.57 |
| Food and Beverage | $11,240.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $326,864.52 | 2019-2025 | Healicoil, Q-Fix, Spatial Frame |
| Stryker Corporation | $138,257.91 | 2019-2025 | Champion, Cinchlock, Hipcheck |
| Vericel Corporation | $91,585.09 | 2019-2025 | Maci |
| Arthrex, INC. | $10,061.72 | 2022-2023 | |
| Micromed INC | $5,191.98 | 2021-2022 | |
| Saxum Surgical, INC. | $4,154.28 | 2022-2023 | |
| Linvatec Corporation | $554.97 | 2019-2022 | |
| Depuy Synthes Sales INC. | $470.55 | 2019-2021 | |
| Ossur Americas, INC. | $142.22 | 2024 | Miami J |
| Conmed Corporation | $125.80 | 2021 | |
| Djo, LLC | $122.20 | 2024 | Donjoy |
| Innovation Technologies INC | $62.50 | 2021 | |
| Aesculap Biologics, LLC | $36.79 | 2021 | |
| Bioventus LLC | $23.96 | 2019 | |
| Pacira Therapeutics, INC. | $23.43 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $17.35 | 2019 | |
| Dynasplint Systems INC. | $15.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Banffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.